- Article metrics
- Last updated: Sun, 12 Oct 2025 20:47:35 Z
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
Access & Citations
-
- 12k
- Article Accesses
-
- 753
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 6 tweeters
- 1 blogs
- 3 news outlets
- 490 Mendeley
This article is in the 92nd percentile (ranked 30,603rd) of the 404,340 tracked articles of a similar age in all journals and the 94th percentile (ranked 7th) of the 120 tracked articles of a similar age in British Journal of Cancer
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
The Promise of RNA-Based Therapies
Morning Star -
The Promise of RNA-Based Therapies
Yahoo! Finance USA -
2024諾貝爾生醫獎落「小分子核糖核酸」,超迷你卻強大!將成癌症治療新希望?
Yahoo! News -
Noncoding RNA Therapies
In the Pipeline
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.